发明申请
- 专利标题: ANTI-CD27 HUMANIZED MONOCLONAL ANTIBODY
- 专利标题(中): 抗CD27人类单克隆抗体
-
申请号: US12979694申请日: 2010-12-28
-
公开(公告)号: US20120093805A1公开(公告)日: 2012-04-19
- 发明人: Tsuguo KUBOTA
- 申请人: Tsuguo KUBOTA
- 申请人地址: JP Tokyo
- 专利权人: KYOWA HAKKO KIRIN CO., LTD
- 当前专利权人: KYOWA HAKKO KIRIN CO., LTD
- 当前专利权人地址: JP Tokyo
- 主分类号: A61K39/395
- IPC分类号: A61K39/395 ; C12N15/13 ; C12N15/62 ; C12P21/02 ; A61P13/12 ; G01N33/574 ; C12N5/10 ; C12N1/21 ; C12N1/19 ; A61P35/00 ; C07K16/28 ; G01N33/566
摘要:
The present invention provides a monoclonal antibody which specifically recognizes CD27 containing an O-linked sugar chain to which galactose is not bound and binds to its extracellular region, or a method for using the same. The present invention can provide a monoclonal antibody or an antibody fragment thereof, which specifically recognizes a polypeptide encoded by CD27 gene containing an O-linked sugar chain to which galactose is not bound, and binds to its extracellular region; a hybridoma which produces the antibody; a DNA which encodes the antibody; a vector which comprises the DNA; a transformant obtainable by transforming the vector; a process for producing an antibody or an antibody fragment thereof using the hybridoma or the transformant; and a diagnostic agent or a therapeutic agent comprising the antibody or the antibody fragment thereof as an active ingredient.
公开/授权文献
- US09403914B2 Anti-CD27 humanized monoclonal antibody 公开/授权日:2016-08-02
信息查询